Flow cytometric analysis of lymphoid cells in thymic epithelial neoplasms
Objective: There have been conflicts concerning the criteria for diagnosing malignant epithelial neoplasms of thymic origin. To differentiate thymic carcinomas from thymomas, the maturation stage of T-lineage lymphoid cells infiltrating thymomas and thymic carcinomas was examined by flow cytometry t...
Gespeichert in:
Veröffentlicht in: | European journal of cardio-thoracic surgery 2000-09, Vol.18 (3), p.287-292 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 292 |
---|---|
container_issue | 3 |
container_start_page | 287 |
container_title | European journal of cardio-thoracic surgery |
container_volume | 18 |
creator | Nakajima, Jun Takamoto, Shinichi Oka, Teruaki Tanaka, Makoto Takeuchi, Eriho Murakawa, Tomohiro |
description | Objective: There have been conflicts concerning the criteria for diagnosing malignant epithelial neoplasms of thymic origin. To differentiate thymic carcinomas from thymomas, the maturation stage of T-lineage lymphoid cells infiltrating thymomas and thymic carcinomas was examined by flow cytometry to associate it with the degree of tumor malignancy. Methods: Multidimensional flow cytometric analysis was performed on the lymphoid cells extracted from 27 thymic epithelial neoplasms (14 encapsulated thymomas, ten invasive thymomas, and three thymic carcinomas) by using anti-CD3, -CD4, -CD8, -CD10, -CD20, -CD38, -CD45RA, and -CD45RO monoclonal antibodies. Results: CD4 and CD8 were co-expressed on 76.8% of the lymphoid cells in encapsulated thymoma (n=14), 59.2% in invasive thymoma (n=10), and 6.7% in thymic cancer (n=3). The percentage of CD4- or CD8- single positive cells was 11.4% in encapsulated thymoma, 23.9% in invasive thymoma, and 77.7% in thymic cancer. The percentage of CD10-positive cells was 20.8% in encapsulated thymoma, 13.2% in invasive thymoma, and 6.0% in thymic cancer. The percentage of CD20-positive cell was 2.6% in encapsulated thymoma, 3.3% in invasive thymoma, and 31.6% in thymic cancer. There were significant statistical differences in the percentages of CD4/CD8 double positive cells, CD4- or CD8-single positive cells, CD10-positive cells and CD20-positive cells among the three groups. Two cases classified as invasive thymoma by pathohistological examination, however, showed the infiltration of mature lymphocytes like as thymic cancers. Conclusions: CD4+CD8+ or CD10+ T-lineage cells were the most reliable markers of the benignancy of thymic epithelial tumors. CD4- or CD8-single positive cells or CD20-positive cells were characteristic in thymic carcinoma. Flow cytometry on the maturity of lymphoid cells infiltrating thymic epithelial tumors was feasible for determining their degree of malignancy. Some invasive thymomas showed the intermediate characteristics with thymomatous epithelia and mature lymphoid cells. |
doi_str_mv | 10.1016/S1010-7940(00)00523-6 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72232670</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1016/S1010-7940(00)00523-6</oup_id><sourcerecordid>72232670</sourcerecordid><originalsourceid>FETCH-LOGICAL-c514t-f6019c850b81925fc71a25a958e4fdc2afea2b8676faa3ed6588e05050415de93</originalsourceid><addsrcrecordid>eNptkE9v1DAQxa0K1JbCRyjKASE4GMZ2bCfHqmJpRSWE-KOqF2vWsbWmziaNs4J8exyylCIhj-w5_N688SPklMEbBky9_ZxvoLou4RXAawDJBVUH5JhVWlAtyutHuf-DHJEnKX0HACW4PiRHDGotpNDH5HIVux-FncaudeMQbIFbjFMKqeh8Eae233ShKayLMRVhW4ybqc2Q68O4cTFgLLau6yOmNj0ljz3G5J7t3xPydfXuy_kFvfr4_vL87IpaycqRegWstpWEdcVqLr3VDLnEWlau9I3l6B3ydaW08ojCNUpWlQOZT8lk42pxQl4uc_uhu9u5NJo2pHlBzKvsktGcC640ZFAuoB26lAbnTT-EFofJMDBzhuZ3hmYOyMBcOUOjsu753mC3bl3zQLWEloEXewCTxegH3NqQ_nL5n0rM_rBg3a7_vzX9x5rO1nSRhDS6n_ciHG6N0kJLc3F9Yz7Uq2-a1Tfmk_gFYcKWeA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72232670</pqid></control><display><type>article</type><title>Flow cytometric analysis of lymphoid cells in thymic epithelial neoplasms</title><source>MEDLINE</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Nakajima, Jun ; Takamoto, Shinichi ; Oka, Teruaki ; Tanaka, Makoto ; Takeuchi, Eriho ; Murakawa, Tomohiro</creator><creatorcontrib>Nakajima, Jun ; Takamoto, Shinichi ; Oka, Teruaki ; Tanaka, Makoto ; Takeuchi, Eriho ; Murakawa, Tomohiro</creatorcontrib><description>Objective: There have been conflicts concerning the criteria for diagnosing malignant epithelial neoplasms of thymic origin. To differentiate thymic carcinomas from thymomas, the maturation stage of T-lineage lymphoid cells infiltrating thymomas and thymic carcinomas was examined by flow cytometry to associate it with the degree of tumor malignancy. Methods: Multidimensional flow cytometric analysis was performed on the lymphoid cells extracted from 27 thymic epithelial neoplasms (14 encapsulated thymomas, ten invasive thymomas, and three thymic carcinomas) by using anti-CD3, -CD4, -CD8, -CD10, -CD20, -CD38, -CD45RA, and -CD45RO monoclonal antibodies. Results: CD4 and CD8 were co-expressed on 76.8% of the lymphoid cells in encapsulated thymoma (n=14), 59.2% in invasive thymoma (n=10), and 6.7% in thymic cancer (n=3). The percentage of CD4- or CD8- single positive cells was 11.4% in encapsulated thymoma, 23.9% in invasive thymoma, and 77.7% in thymic cancer. The percentage of CD10-positive cells was 20.8% in encapsulated thymoma, 13.2% in invasive thymoma, and 6.0% in thymic cancer. The percentage of CD20-positive cell was 2.6% in encapsulated thymoma, 3.3% in invasive thymoma, and 31.6% in thymic cancer. There were significant statistical differences in the percentages of CD4/CD8 double positive cells, CD4- or CD8-single positive cells, CD10-positive cells and CD20-positive cells among the three groups. Two cases classified as invasive thymoma by pathohistological examination, however, showed the infiltration of mature lymphocytes like as thymic cancers. Conclusions: CD4+CD8+ or CD10+ T-lineage cells were the most reliable markers of the benignancy of thymic epithelial tumors. CD4- or CD8-single positive cells or CD20-positive cells were characteristic in thymic carcinoma. Flow cytometry on the maturity of lymphoid cells infiltrating thymic epithelial tumors was feasible for determining their degree of malignancy. Some invasive thymomas showed the intermediate characteristics with thymomatous epithelia and mature lymphoid cells.</description><identifier>ISSN: 1010-7940</identifier><identifier>EISSN: 1873-734X</identifier><identifier>DOI: 10.1016/S1010-7940(00)00523-6</identifier><identifier>PMID: 10973537</identifier><identifier>CODEN: EJCSE7</identifier><language>eng</language><publisher>Amsterdam: Elsevier Science B.V</publisher><subject>Adult ; Aged ; Antigens, CD - immunology ; Biological and medical sciences ; Carcinoma - immunology ; Carcinoma - pathology ; Carcinoma - surgery ; CD10 ; CD4-positive lymphocytes ; CD8-positive lymphocytes ; Diagnosis, Differential ; Female ; Flow Cytometry ; Humans ; Lymphocyte Count - methods ; Male ; Medical sciences ; Middle Aged ; Neoplasm Staging ; Pneumology ; Retrospective Studies ; T-Lymphocytes - immunology ; T-Lymphocytes - pathology ; Thymectomy ; Thymoma ; Thymoma - immunology ; Thymoma - pathology ; Thymoma - surgery ; Thymus neoplasms ; Thymus Neoplasms - immunology ; Thymus Neoplasms - pathology ; Thymus Neoplasms - surgery ; Tumors of the respiratory system and mediastinum</subject><ispartof>European journal of cardio-thoracic surgery, 2000-09, Vol.18 (3), p.287-292</ispartof><rights>Elsevier Science B.V. © 2000 Elsevier Science B.V. All rights reserved. 2000</rights><rights>2000 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c514t-f6019c850b81925fc71a25a958e4fdc2afea2b8676faa3ed6588e05050415de93</citedby><cites>FETCH-LOGICAL-c514t-f6019c850b81925fc71a25a958e4fdc2afea2b8676faa3ed6588e05050415de93</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>309,310,314,776,780,785,786,23910,23911,25119,27903,27904</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1514630$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10973537$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nakajima, Jun</creatorcontrib><creatorcontrib>Takamoto, Shinichi</creatorcontrib><creatorcontrib>Oka, Teruaki</creatorcontrib><creatorcontrib>Tanaka, Makoto</creatorcontrib><creatorcontrib>Takeuchi, Eriho</creatorcontrib><creatorcontrib>Murakawa, Tomohiro</creatorcontrib><title>Flow cytometric analysis of lymphoid cells in thymic epithelial neoplasms</title><title>European journal of cardio-thoracic surgery</title><addtitle>Eur J Cardiothorac Surg</addtitle><addtitle>Eur J Cardiothorac Surg</addtitle><description>Objective: There have been conflicts concerning the criteria for diagnosing malignant epithelial neoplasms of thymic origin. To differentiate thymic carcinomas from thymomas, the maturation stage of T-lineage lymphoid cells infiltrating thymomas and thymic carcinomas was examined by flow cytometry to associate it with the degree of tumor malignancy. Methods: Multidimensional flow cytometric analysis was performed on the lymphoid cells extracted from 27 thymic epithelial neoplasms (14 encapsulated thymomas, ten invasive thymomas, and three thymic carcinomas) by using anti-CD3, -CD4, -CD8, -CD10, -CD20, -CD38, -CD45RA, and -CD45RO monoclonal antibodies. Results: CD4 and CD8 were co-expressed on 76.8% of the lymphoid cells in encapsulated thymoma (n=14), 59.2% in invasive thymoma (n=10), and 6.7% in thymic cancer (n=3). The percentage of CD4- or CD8- single positive cells was 11.4% in encapsulated thymoma, 23.9% in invasive thymoma, and 77.7% in thymic cancer. The percentage of CD10-positive cells was 20.8% in encapsulated thymoma, 13.2% in invasive thymoma, and 6.0% in thymic cancer. The percentage of CD20-positive cell was 2.6% in encapsulated thymoma, 3.3% in invasive thymoma, and 31.6% in thymic cancer. There were significant statistical differences in the percentages of CD4/CD8 double positive cells, CD4- or CD8-single positive cells, CD10-positive cells and CD20-positive cells among the three groups. Two cases classified as invasive thymoma by pathohistological examination, however, showed the infiltration of mature lymphocytes like as thymic cancers. Conclusions: CD4+CD8+ or CD10+ T-lineage cells were the most reliable markers of the benignancy of thymic epithelial tumors. CD4- or CD8-single positive cells or CD20-positive cells were characteristic in thymic carcinoma. Flow cytometry on the maturity of lymphoid cells infiltrating thymic epithelial tumors was feasible for determining their degree of malignancy. Some invasive thymomas showed the intermediate characteristics with thymomatous epithelia and mature lymphoid cells.</description><subject>Adult</subject><subject>Aged</subject><subject>Antigens, CD - immunology</subject><subject>Biological and medical sciences</subject><subject>Carcinoma - immunology</subject><subject>Carcinoma - pathology</subject><subject>Carcinoma - surgery</subject><subject>CD10</subject><subject>CD4-positive lymphocytes</subject><subject>CD8-positive lymphocytes</subject><subject>Diagnosis, Differential</subject><subject>Female</subject><subject>Flow Cytometry</subject><subject>Humans</subject><subject>Lymphocyte Count - methods</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Neoplasm Staging</subject><subject>Pneumology</subject><subject>Retrospective Studies</subject><subject>T-Lymphocytes - immunology</subject><subject>T-Lymphocytes - pathology</subject><subject>Thymectomy</subject><subject>Thymoma</subject><subject>Thymoma - immunology</subject><subject>Thymoma - pathology</subject><subject>Thymoma - surgery</subject><subject>Thymus neoplasms</subject><subject>Thymus Neoplasms - immunology</subject><subject>Thymus Neoplasms - pathology</subject><subject>Thymus Neoplasms - surgery</subject><subject>Tumors of the respiratory system and mediastinum</subject><issn>1010-7940</issn><issn>1873-734X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNptkE9v1DAQxa0K1JbCRyjKASE4GMZ2bCfHqmJpRSWE-KOqF2vWsbWmziaNs4J8exyylCIhj-w5_N688SPklMEbBky9_ZxvoLou4RXAawDJBVUH5JhVWlAtyutHuf-DHJEnKX0HACW4PiRHDGotpNDH5HIVux-FncaudeMQbIFbjFMKqeh8Eae233ShKayLMRVhW4ybqc2Q68O4cTFgLLau6yOmNj0ljz3G5J7t3xPydfXuy_kFvfr4_vL87IpaycqRegWstpWEdcVqLr3VDLnEWlau9I3l6B3ydaW08ojCNUpWlQOZT8lk42pxQl4uc_uhu9u5NJo2pHlBzKvsktGcC640ZFAuoB26lAbnTT-EFofJMDBzhuZ3hmYOyMBcOUOjsu753mC3bl3zQLWEloEXewCTxegH3NqQ_nL5n0rM_rBg3a7_vzX9x5rO1nSRhDS6n_ciHG6N0kJLc3F9Yz7Uq2-a1Tfmk_gFYcKWeA</recordid><startdate>20000901</startdate><enddate>20000901</enddate><creator>Nakajima, Jun</creator><creator>Takamoto, Shinichi</creator><creator>Oka, Teruaki</creator><creator>Tanaka, Makoto</creator><creator>Takeuchi, Eriho</creator><creator>Murakawa, Tomohiro</creator><general>Elsevier Science B.V</general><general>Elsevier Science</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20000901</creationdate><title>Flow cytometric analysis of lymphoid cells in thymic epithelial neoplasms</title><author>Nakajima, Jun ; Takamoto, Shinichi ; Oka, Teruaki ; Tanaka, Makoto ; Takeuchi, Eriho ; Murakawa, Tomohiro</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c514t-f6019c850b81925fc71a25a958e4fdc2afea2b8676faa3ed6588e05050415de93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Antigens, CD - immunology</topic><topic>Biological and medical sciences</topic><topic>Carcinoma - immunology</topic><topic>Carcinoma - pathology</topic><topic>Carcinoma - surgery</topic><topic>CD10</topic><topic>CD4-positive lymphocytes</topic><topic>CD8-positive lymphocytes</topic><topic>Diagnosis, Differential</topic><topic>Female</topic><topic>Flow Cytometry</topic><topic>Humans</topic><topic>Lymphocyte Count - methods</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Neoplasm Staging</topic><topic>Pneumology</topic><topic>Retrospective Studies</topic><topic>T-Lymphocytes - immunology</topic><topic>T-Lymphocytes - pathology</topic><topic>Thymectomy</topic><topic>Thymoma</topic><topic>Thymoma - immunology</topic><topic>Thymoma - pathology</topic><topic>Thymoma - surgery</topic><topic>Thymus neoplasms</topic><topic>Thymus Neoplasms - immunology</topic><topic>Thymus Neoplasms - pathology</topic><topic>Thymus Neoplasms - surgery</topic><topic>Tumors of the respiratory system and mediastinum</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nakajima, Jun</creatorcontrib><creatorcontrib>Takamoto, Shinichi</creatorcontrib><creatorcontrib>Oka, Teruaki</creatorcontrib><creatorcontrib>Tanaka, Makoto</creatorcontrib><creatorcontrib>Takeuchi, Eriho</creatorcontrib><creatorcontrib>Murakawa, Tomohiro</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of cardio-thoracic surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nakajima, Jun</au><au>Takamoto, Shinichi</au><au>Oka, Teruaki</au><au>Tanaka, Makoto</au><au>Takeuchi, Eriho</au><au>Murakawa, Tomohiro</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Flow cytometric analysis of lymphoid cells in thymic epithelial neoplasms</atitle><jtitle>European journal of cardio-thoracic surgery</jtitle><stitle>Eur J Cardiothorac Surg</stitle><addtitle>Eur J Cardiothorac Surg</addtitle><date>2000-09-01</date><risdate>2000</risdate><volume>18</volume><issue>3</issue><spage>287</spage><epage>292</epage><pages>287-292</pages><issn>1010-7940</issn><eissn>1873-734X</eissn><coden>EJCSE7</coden><abstract>Objective: There have been conflicts concerning the criteria for diagnosing malignant epithelial neoplasms of thymic origin. To differentiate thymic carcinomas from thymomas, the maturation stage of T-lineage lymphoid cells infiltrating thymomas and thymic carcinomas was examined by flow cytometry to associate it with the degree of tumor malignancy. Methods: Multidimensional flow cytometric analysis was performed on the lymphoid cells extracted from 27 thymic epithelial neoplasms (14 encapsulated thymomas, ten invasive thymomas, and three thymic carcinomas) by using anti-CD3, -CD4, -CD8, -CD10, -CD20, -CD38, -CD45RA, and -CD45RO monoclonal antibodies. Results: CD4 and CD8 were co-expressed on 76.8% of the lymphoid cells in encapsulated thymoma (n=14), 59.2% in invasive thymoma (n=10), and 6.7% in thymic cancer (n=3). The percentage of CD4- or CD8- single positive cells was 11.4% in encapsulated thymoma, 23.9% in invasive thymoma, and 77.7% in thymic cancer. The percentage of CD10-positive cells was 20.8% in encapsulated thymoma, 13.2% in invasive thymoma, and 6.0% in thymic cancer. The percentage of CD20-positive cell was 2.6% in encapsulated thymoma, 3.3% in invasive thymoma, and 31.6% in thymic cancer. There were significant statistical differences in the percentages of CD4/CD8 double positive cells, CD4- or CD8-single positive cells, CD10-positive cells and CD20-positive cells among the three groups. Two cases classified as invasive thymoma by pathohistological examination, however, showed the infiltration of mature lymphocytes like as thymic cancers. Conclusions: CD4+CD8+ or CD10+ T-lineage cells were the most reliable markers of the benignancy of thymic epithelial tumors. CD4- or CD8-single positive cells or CD20-positive cells were characteristic in thymic carcinoma. Flow cytometry on the maturity of lymphoid cells infiltrating thymic epithelial tumors was feasible for determining their degree of malignancy. Some invasive thymomas showed the intermediate characteristics with thymomatous epithelia and mature lymphoid cells.</abstract><cop>Amsterdam</cop><pub>Elsevier Science B.V</pub><pmid>10973537</pmid><doi>10.1016/S1010-7940(00)00523-6</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1010-7940 |
ispartof | European journal of cardio-thoracic surgery, 2000-09, Vol.18 (3), p.287-292 |
issn | 1010-7940 1873-734X |
language | eng |
recordid | cdi_proquest_miscellaneous_72232670 |
source | MEDLINE; Oxford University Press Journals All Titles (1996-Current); EZB-FREE-00999 freely available EZB journals |
subjects | Adult Aged Antigens, CD - immunology Biological and medical sciences Carcinoma - immunology Carcinoma - pathology Carcinoma - surgery CD10 CD4-positive lymphocytes CD8-positive lymphocytes Diagnosis, Differential Female Flow Cytometry Humans Lymphocyte Count - methods Male Medical sciences Middle Aged Neoplasm Staging Pneumology Retrospective Studies T-Lymphocytes - immunology T-Lymphocytes - pathology Thymectomy Thymoma Thymoma - immunology Thymoma - pathology Thymoma - surgery Thymus neoplasms Thymus Neoplasms - immunology Thymus Neoplasms - pathology Thymus Neoplasms - surgery Tumors of the respiratory system and mediastinum |
title | Flow cytometric analysis of lymphoid cells in thymic epithelial neoplasms |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T06%3A06%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Flow%20cytometric%20analysis%20of%20lymphoid%20cells%20in%20thymic%20epithelial%20neoplasms&rft.jtitle=European%20journal%20of%20cardio-thoracic%20surgery&rft.au=Nakajima,%20Jun&rft.date=2000-09-01&rft.volume=18&rft.issue=3&rft.spage=287&rft.epage=292&rft.pages=287-292&rft.issn=1010-7940&rft.eissn=1873-734X&rft.coden=EJCSE7&rft_id=info:doi/10.1016/S1010-7940(00)00523-6&rft_dat=%3Cproquest_cross%3E72232670%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=72232670&rft_id=info:pmid/10973537&rft_oup_id=10.1016/S1010-7940(00)00523-6&rfr_iscdi=true |